• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非线性分布映射(NoDiM)在淀粉样蛋白-PET 示踪剂之间的调和。

Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.

机构信息

Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; The Florey Institute, The University of Melbourne, Victoria, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Victoria, Australia.

出版信息

Neuroimage. 2019 Feb 1;186:446-454. doi: 10.1016/j.neuroimage.2018.11.019. Epub 2018 Nov 17.

DOI:10.1016/j.neuroimage.2018.11.019
PMID:30458305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6338495/
Abstract

INTRODUCTION

There is a growing need in clinical research domains for direct comparability between amyloid-beta (Aβ) Positron Emission Tomography (PET) measures obtained via different radiotracers and processing methodologies. Previous efforts to provide a common measurement scale fail to account for non-linearities between measurement scales that can arise from these differences. We introduce a new application of distribution mapping, based on well established statistical orthodoxy, that we call Nonlinear Distribution Mapping (NoDiM). NoDiM uses cumulative distribution functions to derive mappings between Aβ-PET measurements from different tracers and processing streams that align data based on their location in their respective distributions.

METHODS

Utilizing large datasets of Florbetapir (FBP) from the Alzheimer's Disease Neuroimaging Initiative (n = 349 female (%) = 53) and Pittsburgh Compound B (PiB) from the Harvard Aging Brain Study (n = 305 female (%) = 59.3) and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (n = 184 female (%) = 53.3), we fit explicit mathematical models of a mixture of two normal distributions, with parameter estimates from Gaussian Mixture Models, to each tracer's empirical data. We demonstrate the accuracy of these fits, and then show the ability of NoDiM to transform FBP measurements into PiB-like units.

RESULTS

A mixture of two normal distributions fit both the FBP and PiB empirical data and provides a strong basis for derivation of a transfer function. Transforming Aβ-PET data with NoDiM results in FBP and PiB distributions that are closely aligned throughout their entire range, while a linear transformation does not. Additionally the NoDiM transform better matches true positive and false positive profiles across tracers.

DISCUSSION

The NoDiM transformation provides a useful alternative to the linear mapping advocated in the Centiloid project, and provides improved correspondence between measurements from different tracers across the range of observed values. This improved alignment enables disparate measures to be merged on to continuous scale, and better enables the use of uniform thresholds across tracers.

摘要

简介

在临床研究领域,人们越来越需要对通过不同示踪剂和处理方法获得的淀粉样蛋白-β(Aβ)正电子发射断层扫描(PET)测量值进行直接比较。以前,为提供通用测量尺度所做的努力未能考虑到可能由于这些差异而产生的测量尺度之间的非线性关系。我们引入了一种新的分布映射应用,该应用基于成熟的统计正统理论,我们称之为非线性分布映射(NoDiM)。NoDiM 使用累积分布函数来推导来自不同示踪剂和处理流的 Aβ-PET 测量值之间的映射,该映射根据其在各自分布中的位置对数据进行对齐。

方法

利用来自阿尔茨海默病神经影像学倡议(n=349 名女性(%=53)的 Florbetapir(FBP)和哈佛衰老大脑研究(n=305 名女性(%=59.3)的 Pittsburgh 复合 B(PiB)以及澳大利亚成像、生物标志物和生活方式老化旗舰研究(n=184 名女性(%=53.3)的大型数据集,我们对每个示踪剂的经验数据拟合了两个正态分布混合的显式数学模型,参数估计来自高斯混合模型。我们展示了这些拟合的准确性,然后展示了 NoDiM 将 FBP 测量值转换为 PiB 样单位的能力。

结果

两个正态分布的混合很好地拟合了 FBP 和 PiB 的经验数据,为推导传递函数提供了坚实的基础。使用 NoDiM 转换 Aβ-PET 数据会导致 FBP 和 PiB 分布在整个范围内紧密对齐,而线性转换则不会。此外,NoDiM 转换更好地匹配了示踪剂之间的真阳性和假阳性分布。

讨论

NoDiM 转换为 Centiloid 项目中提倡的线性映射提供了一种有用的替代方法,并在观察值范围内改善了来自不同示踪剂的测量值之间的对应关系。这种改进的对齐方式使不同的测量值能够合并到连续的尺度上,并能够更好地在示踪剂之间使用统一的阈值。

相似文献

1
Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.非线性分布映射(NoDiM)在淀粉样蛋白-PET 示踪剂之间的调和。
Neuroimage. 2019 Feb 1;186:446-454. doi: 10.1016/j.neuroimage.2018.11.019. Epub 2018 Nov 17.
2
Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.利用多感兴趣区和机器学习技术协调 florbetapir 和 PiB PET 测量的皮质 Aβ斑块负担:替代 Centiloid 方法。
Alzheimers Dement. 2024 Mar;20(3):2165-2172. doi: 10.1002/alz.13677. Epub 2024 Jan 26.
3
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.阿尔茨海默病的淀粉样蛋白成像:氟比拉嗪和匹兹堡化合物-B 正电子发射断层扫描的比较。
J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):923-6. doi: 10.1136/jnnp-2012-302548. Epub 2012 Jul 11.
4
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
5
Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.将脑脊液 Aβ42 测量值转化为计算得到的匹兹堡化合物 B 单位的脑 Aβ 淀粉样蛋白。
Alzheimers Dement. 2011 Mar;7(2):133-41. doi: 10.1016/j.jalz.2010.08.230. Epub 2011 Feb 1.
6
Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.淀粉样β成像用匹兹堡化合物 B 和氟比他滨:比较放射性示踪剂和定量方法。
J Nucl Med. 2013 Jan;54(1):70-7. doi: 10.2967/jnumed.112.109009. Epub 2012 Nov 19.
7
Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.使用18F-氟代贝他吡PET和标准化摄取值比率测量纵向β-淀粉样蛋白变化。
J Nucl Med. 2015 Apr;56(4):567-74. doi: 10.2967/jnumed.114.148981. Epub 2015 Mar 5.
8
Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.欧洲和北美队列中的淀粉样蛋白正电子发射断层扫描;以及探讨年龄作为淀粉样蛋白成像临床应用的限制因素。
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1492-506. doi: 10.1007/s00259-015-3115-5. Epub 2015 Jul 2.
9
Implementing the centiloid transformation for C-PiB and β-amyloid F-PET tracers using CapAIBL.使用 CapAIBL 实现 C-PiB 和 β-淀粉样蛋白 F-PET 示踪剂的百分位数转换。
Neuroimage. 2018 Dec;183:387-393. doi: 10.1016/j.neuroimage.2018.08.044. Epub 2018 Aug 18.
10
Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.基于体素的阿尔茨海默病 PET 成像三探针分析:PIB、FDDNP 和 FDG。
Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.

引用本文的文献

1
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.阿尔茨海默病淀粉样蛋白PET和脑脊液生物标志物临床应用的考量
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.
2
Evaluation of ComBat Harmonization for Reducing Across-Tracer Differences in Regional Amyloid PET Analyses.评估 ComBat 调和法减少区域淀粉样 PET 分析中的跨示踪剂差异。
Hum Brain Mapp. 2024 Nov;45(16):e70068. doi: 10.1002/hbm.70068.
3
Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older Adults.

本文引用的文献

1
Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies.利用 Centiloid 量表进行 PiB PET 研究的横断和纵向分析。
Neuroimage Clin. 2018 Apr 25;19:406-416. doi: 10.1016/j.nicl.2018.04.022. eCollection 2018.
2
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.性别、淀粉样蛋白、载脂蛋白 E ε4 与临床前阿尔茨海默病认知衰退的风险:三个特征明确队列的研究结果。
Alzheimers Dement. 2018 Sep;14(9):1193-1203. doi: 10.1016/j.jalz.2018.04.010. Epub 2018 May 24.
3
F-Florbetaben PET beta-amyloid binding expressed in Centiloids.
认知正常的老年人抑郁症状的变化与纵向区域性淀粉样蛋白积累。
JAMA Netw Open. 2024 Aug 1;7(8):e2427248. doi: 10.1001/jamanetworkopen.2024.27248.
4
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.糖尿病预防试验(DIAN)中15年的纵向基因、临床、认知、影像学和生化测量
medRxiv. 2024 Aug 9:2024.08.08.24311689. doi: 10.1101/2024.08.08.24311689.
5
Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer's disease.空间范围作为临床前阿尔茨海默病中淀粉样蛋白-PET 的敏感指标。
Alzheimers Dement. 2024 Aug;20(8):5434-5449. doi: 10.1002/alz.14036. Epub 2024 Jul 10.
6
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.使用全脑直方图和 Top20%-Map 的新型淀粉样 PET/CT 客观简单评估方法。
Ann Nucl Med. 2024 Sep;38(9):763-773. doi: 10.1007/s12149-024-01956-y. Epub 2024 Jun 22.
7
Multimodal brain age prediction using machine learning: combining structural MRI and 5-HT2AR PET-derived features.基于机器学习的多模态脑龄预测:结合结构 MRI 和 5-HT2AR PET 衍生特征。
Geroscience. 2024 Oct;46(5):4123-4133. doi: 10.1007/s11357-024-01148-6. Epub 2024 Apr 26.
8
A guide for researchers seeking training in retrospective data harmonization for population neuroscience studies of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症人群神经科学研究回顾性数据协调培训指南,供研究人员参考。
Front Neuroimaging. 2022;1. doi: 10.3389/fnimg.2022.978350. Epub 2022 Sep 26.
9
Probabilistic estimation for across-batch compatibility enhancement for amyloid PET.淀粉样蛋白正电子发射断层扫描(amyloid PET)跨批次兼容性增强的概率估计
Alzheimers Dement (Amst). 2023 Jul 5;15(3):e12436. doi: 10.1002/dad2.12436. eCollection 2023 Jul-Sep.
10
Operationalizing the centiloid scale for [F]florbetapir PET studies on PET/MRI.将用于[F] florbetapir PET研究的PET/MRI的百分位数量表付诸实践。
Alzheimers Dement (Amst). 2023 May 16;15(2):e12434. doi: 10.1002/dad2.12434. eCollection 2023 Apr-Jun.
F-Florbetaben PET 以百分位值表示的β-淀粉样蛋白结合。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2053-2059. doi: 10.1007/s00259-017-3749-6. Epub 2017 Jun 22.
4
Functional network integrity presages cognitive decline in preclinical Alzheimer disease.功能网络完整性预示着临床前阿尔茨海默病的认知衰退。
Neurology. 2017 Jul 4;89(1):29-37. doi: 10.1212/WNL.0000000000004059. Epub 2017 Jun 7.
5
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
6
Recruiting to preclinical Alzheimer's disease clinical trials through registries.通过登记处招募参加临床前阿尔茨海默病临床试验的患者。
Alzheimers Dement (N Y). 2017 Jun;3(2):205-212. doi: 10.1016/j.trci.2017.02.004.
7
Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.在临床正常个体中,默认模式网络和突显网络的高连接性和低连接性阶段与淀粉样蛋白和tau蛋白相关。
J Neurosci. 2017 Apr 19;37(16):4323-4331. doi: 10.1523/JNEUROSCI.3263-16.2017. Epub 2017 Mar 17.
8
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.定义脑老化和阿尔茨海默病的影像学生物标志物切点。
Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.
9
Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.不同的部分容积校正方法会得出不同的结论:一项关于衰老的(18)F-FDG-PET研究。
Neuroimage. 2016 May 15;132:334-343. doi: 10.1016/j.neuroimage.2016.02.042. Epub 2016 Feb 23.
10
Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.使用百分等级量表对18F-NAV4694和11C-PiBβ淀粉样蛋白PET结果进行标准化表达。
J Nucl Med. 2016 Aug;57(8):1233-7. doi: 10.2967/jnumed.115.171595. Epub 2016 Feb 16.